These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7435310)

  • 21. Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use.
    Metz VE; Brown QL; Martins SS; Palamar JJ
    Drug Alcohol Depend; 2018 Feb; 183():261-266. PubMed ID: 29310077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polydrug use typologies and childhood maltreatment in a nationally representative survey of Danish young adults.
    Armour C; Shorter GW; Elhai JD; Elklit A; Christoffersen MN
    J Stud Alcohol Drugs; 2014 Jan; 75(1):170-8. PubMed ID: 24411809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Everyday and prospective memory deficits in ecstasy/polydrug users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-esteem and self-derogation theory of drug abuse.
    Kaplan HB
    NIDA Res Monogr; 1980 Mar; 30():128-31. PubMed ID: 6779168
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic self-medication as a context for drug abuse research.
    Bigelow GE; Liebson I; Kaliszak J; Griffiths RR
    NIDA Res Monogr; 1978 Jul; (20):44-58. PubMed ID: 101860
    [No Abstract]   [Full Text] [Related]  

  • 26. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations.
    Bigelow GE; Stitzer ML; Griffiths RR; Liebson IA
    Addict Behav; 1981; 6(3):241-52. PubMed ID: 7293847
    [No Abstract]   [Full Text] [Related]  

  • 28. Personality variables and self-medication in substance abuse.
    Schinka JA; Curtiss G; Mulloy JM
    J Pers Assess; 1994 Dec; 63(3):413-22. PubMed ID: 7844734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
    Scott RM; Hides L; Allen JS; Lubman DI
    Addict Behav; 2013 Oct; 38(10):2465-72. PubMed ID: 23770644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prediction of neuropsychological impairment in polydrug abusers.
    Carlin AS; Stauss FF; Adams KM; Grant I
    Addict Behav; 1978; 3(1):5-12. PubMed ID: 654998
    [No Abstract]   [Full Text] [Related]  

  • 33. Order of onset of substance abuse and depression in a sample of depressed outpatients.
    Abraham HD; Fava M
    Compr Psychiatry; 1999; 40(1):44-50. PubMed ID: 9924877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.
    Griffiths RR; Weerts EM
    Psychopharmacology (Berl); 1997 Nov; 134(1):1-37. PubMed ID: 9399364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance use in severe mental illness: self-medication and vulnerability factors.
    Bizzarri JV; Rucci P; Sbrana A; Miniati M; Raimondi F; Ravani L; Massei GJ; Milani F; Milianti M; Massei G; Gonnelli C; Cassano GB
    Psychiatry Res; 2009 Jan; 165(1-2):88-95. PubMed ID: 19054572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Evaluation of the Lifestyle History Questionnaire (LHQ) for People Entering Treatment for Substance Addictions.
    Martin LM; Triscari R; Boisvert R; Hipp K; Gersten J; West RC; Kisling E; Donham A; Kollar N; Escobar P
    Am J Occup Ther; 2015; 69(3):6903250010p1-9. PubMed ID: 25871597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD.
    Wilens TE; Adamson J; Sgambati S; Whitley J; Santry A; Monuteaux MC; Biederman J
    Am J Addict; 2007; 16 Suppl 1():14-21; quiz 22-3. PubMed ID: 17453603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A qualitative study of illicit and non-prescribed drug use amongst people with psychotic disorders.
    Charles V; Weaver T
    J Ment Health; 2010 Feb; 19(1):99-106. PubMed ID: 20380502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.